Literature DB >> 18502034

Breast cancer metastasis suppressor 1 inhibits SDF-1alpha-induced migration of non-small cell lung cancer by decreasing CXCR4 expression.

Jiyun Yang1, Ben Zhang, Yin Lin, Yang Yang, Xiaoqi Liu, Fang Lu.   

Abstract

This report shows that over-expression of BRMS1 reduces SDF-induced chemotaxis and suppresses nuclear factor-kappaB (NF-kappaB) activity in NSCLC cell line. Inhibition of NF-kappaB activity impairs SDF-1alpha-dependent migration and NF-kappaB can directly bind to the chemokine (C-X-C motif) receptor 4 (CXCR4) promoter invivo. However, knockdown of BRMS1 promotes NSCLC cell migration and CXCR4 expression. Furthermore, BRMS1 and CXCR4 expression levels are inversely correlated in the NSCLC cases. The level of BRMS1 mRNA is found to be markedly lower in the distant metastasis group than in the non-distant metastasis group (P=0.003). However, CXCR4 mRNA was higher in the distant metastasis group than in the non-distant metastasis group (P=0.032). These results indicate that BRMS1 regulates metastatic potential at least in part through the down-regulation of CXCR4, to be indirectly regulated by BRMS1 through nuclear factor-kappaB activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18502034     DOI: 10.1016/j.canlet.2008.04.016

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  21 in total

1.  CXCR4, but not CXCR7, discriminates metastatic behavior in non-small cell lung cancer cells.

Authors:  Young H Choi; Marie D Burdick; Brett A Strieter; Borna Mehrad; Robert M Strieter
Journal:  Mol Cancer Res       Date:  2013-09-11       Impact factor: 5.852

2.  Patient outcome prediction using multiple biomarkers in human melanoma: A clinicopathological study of 118 cases.

Authors:  Jun Li; Zhizhong Zhang; Gang Li
Journal:  Exp Ther Med       Date:  2010-12-02       Impact factor: 2.447

Review 3.  Metastasis suppressor genes at the interface between the environment and tumor cell growth.

Authors:  Douglas R Hurst; Danny R Welch
Journal:  Int Rev Cell Mol Biol       Date:  2011       Impact factor: 6.813

4.  Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis.

Authors:  J Li; Y Cheng; D Tai; M Martinka; D R Welch; G Li
Journal:  Oncogene       Date:  2010-10-11       Impact factor: 9.867

5.  Scinderin is a novel transcriptional target of BRMS1 involved in regulation of hepatocellular carcinoma cell apoptosis.

Authors:  Xiaojing Qiao; Yiren Zhou; Wenjuan Xie; Yi Wang; Yicheng Zhang; Tian Tian; Jianming Dou; Xi Yang; Suqin Shen; Jianwei Hu; Shouyi Qiao; Yanhua Wu
Journal:  Am J Cancer Res       Date:  2018-06-01       Impact factor: 6.166

6.  Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell's Journey.

Authors:  Wen Liu; Carolyn J Vivian; Amanda E Brinker; Kelsey R Hampton; Evi Lianidou; Danny R Welch
Journal:  Cancer Microenviron       Date:  2014-06-18

7.  Linking metastasis suppression with metastamiR regulation.

Authors:  Mick D Edmonds; Douglas R Hurst; Danny R Welch
Journal:  Cell Cycle       Date:  2009-09-23       Impact factor: 4.534

8.  Effect and mechanism of the metastasis suppressor gene BRMS1 on the migration of breast cancer cells.

Authors:  Yin-Long Yang; Cheng-Ze Chen; Lang-Ping Jin; Qian-Qing Ji; Yi-Zuo Chen; Quan Li; Xiao-Hua Zhang; Jin-Miao Qu
Journal:  Int J Clin Exp Med       Date:  2013-10-25

9.  Breast cancer metastasis suppressor 1 (BRMS1) suppresses metastasis and correlates with improved patient survival in non-small cell lung cancer.

Authors:  Philip W Smith; Yuan Liu; Suzanne A Siefert; Christopher A Moskaluk; Gina R Petroni; David R Jones
Journal:  Cancer Lett       Date:  2008-12-25       Impact factor: 8.679

10.  Identification of essential sequences for cellular localization in BRMS1 metastasis suppressor.

Authors:  José Rivera; Diego Megías; Carolina Navas; Jerónimo Bravo
Journal:  PLoS One       Date:  2009-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.